000			02150 a2200625 4500
005			20250517204306.0
264		0	_c20190506
008			201905s 0 0 eng d
022			_a1545-5017
024	7		_a10.1002/pbc.27034 _2doi
040			_aNLM _beng _cNLM
100	1		_aDvorak, Christopher C
245	0	0	_aDisease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study. _h[electronic resource]
260			_bPediatric blood & cancer _c07 2018
300			_ae27034 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
650	0	4	_aBusulfan _xadministration & dosage
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGraft Rejection _xdrug therapy
650	0	4	_aGraft vs Host Disease _xdrug therapy
650	0	4	_aHematopoietic Stem Cell Transplantation _xadverse effects
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aInfant, Newborn
650	0	4	_aLeukemia, Myelomonocytic, Juvenile _xcomplications
650	0	4	_aMale
650	0	4	_aMyeloablative Agonists _xadministration & dosage
650	0	4	_aPrognosis
650	0	4	_aTransplantation Conditioning
650	0	4	_aVidarabine _xadministration & dosage
700	1		_aSatwani, Prakash
700	1		_aStieglitz, Elliot
700	1		_aCairo, Mitchell S
700	1		_aDang, Ha
700	1		_aPei, Qinglin
700	1		_aGao, Yun
700	1		_aWall, Donna
700	1		_aMazor, Tali
700	1		_aOlshen, Adam B
700	1		_aParker, Joel S
700	1		_aKahwash, Samir
700	1		_aHirsch, Betsy
700	1		_aRaimondi, Susana
700	1		_aPatel, Neil
700	1		_aSkeens, Micah
700	1		_aCooper, Todd
700	1		_aMehta, Parinda A
700	1		_aGrupp, Stephan A
700	1		_aLoh, Mignon L
773	0		_tPediatric blood & cancer _gvol. 65 _gno. 7 _gp. e27034
856	4	0	_uhttps://doi.org/10.1002/pbc.27034 _zAvailable from publisher's website
999			_c28168292 _d28168292